Correspondence 0001493152-24-044098 from JUPITER NEUROSCIENCES, INC. (JUNS)
JUPITER NEUROSCIENCES, INC.
Date: Nov. 7, 2024 · CIK: 0001679628 · Accession: 0001493152-24-044098
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-260183
Letter
VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences Attention: Daniel Crawford Re: Jupiter Neurosciences, Inc. (the “Company”) Registration Statement on Form S-1 CIK No. 0001679628 File No. 333-260183 (the “Registration Statement”)
Dear Mr. Crawford and Ms. Hayes:
In accordance with Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, (the “Act”), we hereby join the Company’s request for acceleration of the above-referenced Registration Statement, requesting effectiveness for 5:00 p.m., Eastern Time, on Friday, November 8, 2024, or as soon thereafter as practicable.
Pursuant to Rule 460 under the Act, we wish to advise you that the underwriters have distributed as many copies of the Preliminary Prospectus dated September 13, 2024 to underwriters, dealers, institutions and others as appears to be reasonable to secure adequate distribution of the Preliminary Prospectus.
The undersigned, as the representative of the several underwriters, represents that the several underwriters have and will comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
Please contact Cavas Pavri, Esq. of ArentFox Schiff LLP, counsel of the representative of the underwriters, at (202) 724-6847 to provide notice of effectiveness, or if you have any questions or concerns regarding the foregoing. We appreciate your assistance in this matter.
[Signature page follows]
Very
truly yours,
As
representative of the underwriters
Show Raw Text
CORRESP
1
filename1.htm
DOMINARI SECURITIES LLC
725 Fifth Avenue, 23rd Floor
New York, NY 10022
November
7, 2024
VIA
EDGAR
United
States Securities and Exchange Commission
Division
of Corporation Finance
Office
of Life Sciences
100
F Street, N.E.
Washington,
D.C. 20549
Attention:
Daniel
Crawford
Suzanne
Hayes
Re:
Jupiter
Neurosciences, Inc. (the “Company”)
Registration
Statement on Form S-1
CIK
No. 0001679628
File
No. 333-260183 (the “Registration Statement”)
Dear
Mr. Crawford and Ms. Hayes:
In
accordance with Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, (the “Act”),
we hereby join the Company’s request for acceleration of the above-referenced Registration Statement, requesting effectiveness
for 5:00 p.m., Eastern Time, on Friday, November 8, 2024, or as soon thereafter as practicable.
Pursuant
to Rule 460 under the Act, we wish to advise you that the underwriters have distributed as many copies of the Preliminary Prospectus
dated September 13, 2024 to underwriters, dealers, institutions and others as appears to be reasonable to secure adequate distribution
of the Preliminary Prospectus.
The
undersigned, as the representative of the several underwriters, represents that the several underwriters have and will
comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
Please
contact Cavas Pavri, Esq. of ArentFox Schiff LLP, counsel of the representative of the underwriters, at (202) 724-6847 to provide
notice of effectiveness, or if you have any questions or concerns regarding the foregoing. We appreciate your assistance in this matter.
[Signature
page follows]
Very
truly yours,
As
representative of the underwriters
DOMINARI
SECURITIES LLC
By:
/s/
Eric Newman
Name:
Eric
Newman
Title:
Executive
Vice President